You can buy or sell XOMA and other stocks, options, ETFs, and crypto commission-free!
XOMA Corp. engages in the discovery and development of innovative therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. Read More The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.
52 Week High
52 Week Low
Yahoo FinanceMay 6
XOMA Reports First Quarter 2019 Financial Results and Operating Highlights
Acquired rights to potential milestone and royalty payments associated with five hematology assets Received $5.5 million milestone payment Added Barbara Kosacz to XOMA’s Board of Directors Current cash balance sufficient to fund operations for multiple years EMERYVILLE, Calif., May 06, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (XOMA) announced its first quarter 2019 financial results and business highlights. “We continued to execute on our royalty-aggregator business model in 2019. In early April, we a...
-$0.12 per share
$0.21 per share